Product Information

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.1292 per EA under NDC 42858020150. Its NADAC has been published 549 times since May 18, 2016.

FDA first approved this application on Apr 12, 2016. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1292per EA
DEA Schedule CII

Strength

325; 5 mg/1; mg/1

NDC

42858020150

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202991

FDA Approved

4/12/2016

TE Code

AA

On Market Since

4/12/2016

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has been published 549 times since May 18, 2016, and over the history we have for it it has declined 4.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1292 per EA
All-time high$0.1518 (Jul 10, 2024)
All-time low$0.0764 (Nov 20, 2019)
52-week high$0.1388
52-week low$0.1276
Median price$0.1091
Average price$0.1126
Largest weekly change+33.6% (Jan 22, 2020)
Weeks tracked549
Tracking sinceMay 18, 2016

Price History

1W

-2.1%

1M

-5.1%

3M

-6.7%

6M

-1.4%

1Y

+1.2%

3Y

+3.1%

5Y

+47.4%

All

-4.3%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, manufactured by Rhodes Pharmaceuticals L.P., is $0.1292 per EA (NDC 42858020150), effective Nov 18, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has declined 4.3%. It has been tracked across 549 weekly CMS publications since May 18, 2016.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

Since May 18, 2016, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has ranged from a low of $0.0764 (Nov 20, 2019) to a high of $0.1518 (Jul 10, 2024), with a median of $0.1091 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, is $0.1066 per EA — about 18% below HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET (NDC 42858020150) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.